Agilent Technologies, Inc. (A)

Agilent Technologies' stock price has declined in the past six months. Between July 15, 2024, and July 14, 2025, the share price decreased by 8.34%. More recently, the stock tumbled by 11.7% over the last six months. Key events impacting the stock price include Q2 earnings and guidance, where Agilent surpassed Q2 earnings per share estimates but missed revenue expectations and issued weak guidance, leading to a stock tumble. Agilent slightly lifted its full-year revenue guidance for fiscal year 2025 to a range of $6.73 billion to $6.81 billion. Additionally, the departure of CFO Bob McMahon led to a drop in share price.

Demand seasonality for Agilent Technologies varies by business segment. The Life Sciences and Diagnostics Business is influenced by government and pharmaceutical company budgets, with the third and fourth fiscal quarters typically being the strongest. Electronic Measurement Markets experience lower business levels in the first fiscal quarter and higher volumes in the fourth fiscal quarter. The Agilent CrossLab Business is generally less susceptible to market seasonality.

Agilent Technologies, Inc. is a global leader in life sciences, diagnostics, and applied chemical markets, providing instruments, software, services, and consumables for analytical laboratories. The company operates within the Healthcare sector, specifically in the Medical Diagnostics & Research industry. Agilent's products enable customers to identify, quantify, and analyze the physical and biological properties of substances and products. Key product categories include chromatography systems, spectroscopy systems, cell analysis tools, diagnostics and genomics solutions, laboratory software and automation, and other products like dissolution testing equipment. Agilent also provides extensive services, including maintenance, compliance, training, and software solutions, serving diverse industries such as pharmaceuticals, biotechnology, environmental science, and clinical diagnostics.

Agilent Technologies operates in over 110 countries with research and development centers, manufacturing facilities, sales offices, and customer support centers. In fiscal year 2024, the Americas accounted for 40% of Agilent's revenue, EMEA for 27%, and Asia-Pacific for 33%.

Agilent Technologies has a strong brand reputation built over 20 years, recognized for its reliability and scientific expertise. The company maintains industry-leading customer satisfaction scores and a customer retention rate exceeding 90%. Agilent's focus on workflow productivity and digital solutions differentiates it from competitors. The Agilent Resolve Handheld Raman Spectrometer received multiple recognitions for its excellence as a tool for emergency responders in 2023.

Agilent Technologies is primarily owned by institutional shareholders, who hold between 74.33% and 87.44% of the company's stock. Individual and retail investors own approximately 11.33% to 24.07%, while insiders hold about 1.24% to 0.26%. Major institutional owners include Vanguard Group Inc, BlackRock, Inc., and State Street Corp.